118 related articles for article (PubMed ID: 8676198)
1. Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor.
Kassis AI; Tumeh SS; Wen PY; Baranowska-Kortylewicz J; Van den Abbeele AD; Zimmerman RE; Carvalho PA; Garada BM; DeSisto WC; Bailey NO; Castronovo FP; Mariani G; Black PM; Adelstein SJ
J Nucl Med; 1996 Apr; 37(4 Suppl):19S-22S. PubMed ID: 8676198
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeled nucleoside analogs in cancer diagnosis and therapy.
Kassis AI; Adelstein SJ; Mariani G
Q J Nucl Med; 1996 Sep; 40(3):301-19. PubMed ID: 8961807
[TBL] [Abstract][Full Text] [Related]
3. Tumor targeting by intra-arterial infusion of 5-[123I]iodo-2'-deoxyuridine in patients with liver metastases from colorectal cancer.
Mariani G; Di Sacco S; Volterrani D; Di Luca L; Buralli S; Di Stefano R; Baranowska-Kortylewicz J; Bonora D; Matteucci F; Ricci S; Bellina CR; Falcone A; Salvadori PA; Mosca F; Adelstein SJ; Kassis AI
J Nucl Med; 1996 Apr; 37(4 Suppl):22S-25S. PubMed ID: 8676199
[TBL] [Abstract][Full Text] [Related]
4. Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.
Macapinlac HA; Kemeny N; Daghighian F; Finn R; Zhang J; Humm J; Squire O; Larson SM
J Nucl Med; 1996 Apr; 37(4 Suppl):25S-29S. PubMed ID: 8676200
[TBL] [Abstract][Full Text] [Related]
5. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
Semnani ES; Wang K; Adelstein SJ; Kassis AI
J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
[TBL] [Abstract][Full Text] [Related]
6. Preclinical animal studies with radioiododeoxyuridine.
Kassis AI; Adelstein SJ
J Nucl Med; 1996 Apr; 37(4 Suppl):10S-12S. PubMed ID: 8676195
[TBL] [Abstract][Full Text] [Related]
7. PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomas.
Roelcke U; Hausmann O; Merlo A; Missimer J; Maguire RP; Freitag P; Radü EW; Weinreich R; Gratzl O; Leenders KL
J Nucl Med; 2002 Nov; 43(11):1444-51. PubMed ID: 12411546
[TBL] [Abstract][Full Text] [Related]
8. Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer.
Van den Abbeele AD; Tutrone RF; Berman RM; Baranowska-Kortylewicz J; Barclay PD; Richie JP; Adelstein SJ; Kassis AI
J Nucl Med; 1996 Feb; 37(2):315-20. PubMed ID: 8667069
[TBL] [Abstract][Full Text] [Related]
9. 5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats.
Kassis AI; Wen PY; Van den Abbeele AD; Baranowska-Kortylewicz J; Makrigiorgos GM; Metz KR; Matalka KZ; Cook CU; Sahu SK; Black PM; Adelstein SJ
J Nucl Med; 1998 Jul; 39(7):1148-54. PubMed ID: 9669385
[TBL] [Abstract][Full Text] [Related]
10. 5-[125]iodo-2'-deoxyuridine in the radiotherapy of solid CNS tumors in rats.
Kassis AI; Adelstein SJ
Acta Oncol; 1996; 35(7):935-9. PubMed ID: 9004774
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model.
Mairs RJ; Wideman CL; Angerson WJ; Whateley TL; Reza MS; Reeves JR; Robertson LM; Neshasteh-Riz A; Rampling R; Owens J; Allan D; Graham DI
Br J Cancer; 2000 Jan; 82(1):74-80. PubMed ID: 10638969
[TBL] [Abstract][Full Text] [Related]
12. Tumor uptake and mitotic activity pattern of 5-[125I]iodo-2'- deoxyuridine after intravesical infusion in patients with bladder cancer.
Mariani G; Collecchi P; Baldassarri S; Di Luca L; Buralli S; Fontanini G; Baranowska-Kortylewicz J; Adelstein SJ; Kassis AI
J Nucl Med; 1996 Apr; 37(4 Suppl):16S-19S. PubMed ID: 8676197
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver.
Daghighian F; Humm JL; Macapinlac HA; Zhang J; Izzo J; Finn R; Kemeny N; Larson SM
J Nucl Med; 1996 Apr; 37(4 Suppl):29S-32S. PubMed ID: 8676201
[TBL] [Abstract][Full Text] [Related]
14. Biochemical modulation by 5-fluorouracil and 1-folinic acid of tumor uptake of intra-arterial 5-[123I]iodo-2'deoxyuridine in patients with liver metastases from colorectal cancer.
Mariani G; Di Sacco S; Bonini R; Di Luca L; Buralli S; Bonora D; Ricci S; Baranowska-Kortylewicz J; Adelstein SJ; Falcone A; Kassis AI
Acta Oncol; 1996; 35(7):941-5. PubMed ID: 9004775
[TBL] [Abstract][Full Text] [Related]
15. Tumor targeting in vivo and metabolic fate of 5-[iodine-125]iodo-2'-deoxyuridine following intratumoral injection in patients with colorectal cancer.
Mariani G; Cei A; Collecchi P; Baranowska-Kortylewicz J; Van den Abbeele AD; Di Luca L; Di Stefano R; Viacava P; Ferdeghini EM; Di Sacco S
J Nucl Med; 1993 Jul; 34(7):1175-83. PubMed ID: 8315499
[TBL] [Abstract][Full Text] [Related]
16. 5-[123I]iodo-2'-deoxyuridine in the radiotherapy of an early ascites tumor model.
Baranowska-Kortylewicz J; Makrigiorgos GM; Van den Abbeele AD; Berman RM; Adelstein SJ; Kassis AI
Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1541-51. PubMed ID: 1938564
[TBL] [Abstract][Full Text] [Related]
17. Diesterified derivatives of 5-iodo-2'-deoxyuridine as cerebral tumor tracers.
Rösler TW; Matusch A; Librizzi D; Arias-Carrión O; Freundlieb N; Hoeffken H; Oertel WH; Depboylu C; Höglinger GU
PLoS One; 2014; 9(7):e102397. PubMed ID: 25028935
[TBL] [Abstract][Full Text] [Related]
18. Specific uptake of the auger electron-emitting thymidine analogue 5-[123I/125I]iodo-2'-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans.
Kassis AI; Van den Abbeele AD; Wen PY; Baranowska-Kortylewicz J; Aaronson RA; DeSisto WC; Lampson LA; Black PM; Adelstein SJ
Cancer Res; 1990 Aug; 50(16):5199-203. PubMed ID: 2379179
[TBL] [Abstract][Full Text] [Related]
19. Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire.
Neshasteh-Riz A; Mairs RJ; Angerson WJ; Stanton PD; Reeves JR; Rampling R; Owens J; Wheldon TE
Br J Cancer; 1998; 77(3):385-90. PubMed ID: 9472632
[TBL] [Abstract][Full Text] [Related]
20. Radiolabeled iododeoxyuridine: safety evaluation.
Harrison KA; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Lieberman RP; Sharp JG; Cohen SM; Leichner PK; Augustine SC; Tempero MA; Taylor RJ; Chiou RK
J Nucl Med; 1996 Apr; 37(4 Suppl):13S-16S. PubMed ID: 8676196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
